Back to today’s briefing

Story perspectives

New Anti-Obesity Drugs Show 20% Weight Loss Potential

1/8/2025

26 2

Summary

Story summary

A groundbreaking review from McGill University reveals that innovative anti-obesity medications, including retatrutide and tirzepatide, could outshine current frontrunners like Ozempic. In trials, participants shed over 20% of their body weight, igniting hope for effective weight loss solutions. Yet, worries about potential side effects and steep prices linger in the air.

1 of 1

Story summary

A groundbreaking review from McGill University reveals that innovative anti-obesity medications, including retatrutide and tirzepatide, could outshine current frontrunners like Ozempic. In trials, participants shed over 20% of their body weight, igniting hope for effective weight loss solutions. Yet, worries about potential side effects and steep prices linger in the air.